S-OA-J
Oral Abstracts - Session J - Late Effects/Quality of Life & Supportive Care

Track: BMT Tandem "Scientific" Meeting
Saturday, March 1, 2014: 4:45 PM-6:45 PM
Texas C (Gaylord Texan)
Chairs:
Andrew S. Artz, MD, MS and William A. Wood, MD, MPH

Disclosures:
A. S. Artz, Miltenyi, No role: Research Funding

W. A. Wood, Nothing To Disclose

61
Late Effects in Infants and Young Children Following Umbilical Cord Blood Transplant Using Busulfan-Based, Myeloablative Non-TBI Conditioning Regimens
Heather B Allewelt, MD, Duke University Medical Center; Paul L. Martin, MD, PhD, Duke University Medical Center; Vinod K. Prasad, MD, Duke University Medical Center; Kristin Page, MD, Duke University Medical Center; Joanne Kurtzberg, MD, Duke University Medical Center

62
Coping Strategies Modify the Risk of Depression Associated with Chronic Graft-Versus-Host Disease Severity
Anna Barata, Moffitt Cancer Center; Steve Sutton, PhD, Moffitt Cancer Center; Brent Small, PhD, University of South Florida; Paul Jacobsen, PhD, Moffitt Cancer Center; Heather Jim, PhD, Moffitt Cancer Center

63
Long-Term Survival and Late Effects Among 1-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation (2nd Allo HCT) for Relapsed Acute Leukemia and Myelodysplastic Syndrome: A Report from the Cibmtr
Christine Duncan, MD, Dana-Farber Cancer Institute; Navneet S. Majhail, MD, MS, Cleveland Clinic Foundation; Ruta Brazauskas, PhD, Medical College of Wisconsin; Zhiwei Wang, MS, The Medical College of Wisconsin; Jean-Yves Cahn, MD, University Hospital; Rammurti T. Kamble, MD, Baylor College of Medicine Center for Cell and Gene Therapy; Haydar A. Frangoul, MD, Vanderbilt University Medical Center; Robert J. Hayashi, MD, St. Louis Children's Hospital, University of Washington; Jack W. Hsu, MD, University of Florida; David A. Jacobsohn, Chief, Division of Blood and Marrow Transplantation, Children's National Medical Center; Kimberly A. Kasow, DO, University of North Carolina; Nandita Khera, MD, Mayo Clinic; Hillard M. Lazarus, MD, University Hospitals Case Medical Center; Allison W. Loren, MD, MS, Abramson Cancer Center University of Pennsylvania Medical Center; Richard T. Maziarz, MD, Oregon Health and Science University; Paulette Mehta, MD, MPH, University of Arkansas for Medical Sciences; Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center; Joseph Pidala, MD, MS, H. Lee Moffitt Cancer Center and Research Institute; David L. Porter, MD, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania; Vijay Reddy, MD, PhD, University of Florida; Wael Saber, MD, MS, Medical College of Wisconsin; Harry C. Schouten, MD, PhD, Academische Ziekenhuis Maastricht; Amir Steinberg, MD, Mount Sinai Medical Center; Lolie C Yu, MD, Children's Hospital; Donna A. Wall, MD, CancerCare Manitoba, University of Manitoba; Anne B. Warwick, MD, MPH, Uniformed Services University; William A. Wood, MD, MPH, University of North Carolina Hospitals; Bipin N. Savani, MD, Vanderbilt University Medical Center; Mohamed L. Sorror, MD, MSc, Fred Hutchinson Cancer Research Center

64
The Impact of Age on Quality of Life, Functional Status, and Overall Survival in Patients with Moderate-Severe Chronic Graft-Versus-Host Disease
Areej El-Jawahri, MD, Dana-Farber Cancer Institute; Joseph Pidala, MD, MS, H. Lee Moffitt Cancer Center and Research Institute; Xiaoyu Chai, MS, Clinical Research Division, Fred Hutchinson Cancer Research Center; William A. Wood, MD, MPH, University of North Carolina Hospitals; Nandita Khera, MD, Mayo Clinic; Mukta Arora, MD, MS, University of Minnesota; Samantha Jaglowski, MD, Ohio State University Medical Center; Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center; Yi-Bin Chen, MD, Massachusetts General Hospital

65
Comprehensive Geriatric Assessment Identifies Significant Functional Impairments in Older Hematopoietic Cell Transplant Recipients
Rebecca L. Olin, MD, MSCE, University of California San Francisco; Charalambos Andreadis, MD, MSCE, University of California San Francisco; Thomas G Martin, MD, University of California San Francisco; Jeffrey L Wolf, MD, University of California San Francisco; Lawrence D Kaplan, MD, University of California San Francisco; Weiyun Ai, MD, PhD, University of California San Francisco; Jeffrey M Venstrom, MD, University of California San Francisco; Aaron C Logan, MD, PhD, University of California San Francisco; Catherine C Smith, MD, University of California San Francisco; Karin ML Gaensler, MD, University of California San Francisco; Jimmy Hwang, PhD, University of California San Francisco; Lloyd E Damon, MD, University of California San Francisco

66
Comorbidity, History of Alcohol Disorders, and LDH Predict Non-Relapse Mortality (NRM) Among Recipients of Autologous Hematopoietic Cell Transplantation (HCT) for Lymphoma
Jennifer Eliece Vaughn, MD, MSPH, Fred Hutchinson Cancer Research Center (FHCRC); Barry E. Storer, PhD, Fred Hutchinson Cancer Research Center; Thomas Chauncey, MD, PhD, VA Puget Sound Healthcare System (VAPSHCS); Ajay K. Gopal, MD, Fred Hutchinson Cancer Research Center (FHCRC); Leona Holmberg, MD, PhD, Fred Hutchinson Cancer Research Center (FHCRC); William Bensinger, MD, Fred Hutchinson Cancer Research Center (FHCRC); David G. Maloney, MD, PhD, Fred Hutchinson Cancer Research Center; Oliver W. Press, MD, PhD, Fred Hutchinson Cancer Research Center (FHCRC); Rainer F. Storb, MD, University of Washington; Mohamed L. Sorror, MD, MSc, Fred Hutchinson Cancer Research Center (FHCRC)

67
Risk Factors for Musculoskeletal Symptoms in 5-20 Year Survivors Who Received Myeloablative Hematopoietic Cell Transplant (HCT)
Jean C. Yi, PhD, Fred Hutchinson Cancer Research Center; Paul J. Martin, MD, University of Washington School of Medicine; Barry E. Storer, PhD, Fred Hutchinson Cancer Research Center; Janet R Abrams, PsyD, Fred Hutchinson Cancer Research Center; Samantha B. Artherholt, PhD, Fred Hutchinson Cancer Research Center; Susan M Ott, MD, University of Washington School of Medicine; Mary E.D. Flowers, MD, University of Washington School of Medicine; Karen L. Syrjala, PhD, Fred Hutchinson Cancer Research Center

108
Cibmtr Retrospective Analysis Reveals Incidence, Mortality, and Timing of Pneumocystis Jiroveci Pneumonia (PCP) after Hematopoietic Stem Cell Transplantation (HSCT)
Kirsten M. Williams, MD, National Cancer Institute, NIH; Allison G. Agwu, Johns Hopkins University; Min Chen, MS, Medical College of Wisconsin; Kwang Woo Ahn, PhD, Medical College of Wisconsin; Paul Szabolcs, MD, Children's Hospital of Pittsburgh of UPMC; Michael J. Boeckh, MD, PhD, Fred Hutchinson Cancer Research Center; Jeffery J. Auletta, MD, Nationwide Children's Hospital; Marcie Riches, MD, MS, H. Lee Moffitt Cancer Center